Organogenesis Holdings Inc. Quarterly Cost of Revenue in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Organogenesis Holdings Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2017 to Q2 2024.
  • Organogenesis Holdings Inc. Cost of Revenue for the quarter ending June 30, 2024 was $29.2M, a 11% increase year-over-year.
  • Organogenesis Holdings Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $111M, a 4.94% increase year-over-year.
  • Organogenesis Holdings Inc. annual Cost of Revenue for 2023 was $106M, a 1.39% increase from 2022.
  • Organogenesis Holdings Inc. annual Cost of Revenue for 2022 was $105M, a 8.04% decline from 2021.
  • Organogenesis Holdings Inc. annual Cost of Revenue for 2021 was $114M, a 30.8% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $111M $29.2M +$2.88M +11% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $109M $28.7M +$2.09M +7.85% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $106M $27.8M +$659K +2.43% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $106M $25.8M -$388K -1.48% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $106M $26.3M -$336K -1.26% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $107M $26.6M +$1.53M +6.09% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $105M $27.1M -$5.49M -16.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $111M $26.2M +$10K +0.04% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $110M $26.7M -$3.29M -11% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $114M $25.1M -$415K -1.63% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $114M $32.6M +$7.08M +27.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $107M $26.2M +$3.2M +13.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $104M $29.9M +$9.9M +49.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $94M $25.5M +$6.7M +35.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $87.3M $25.5M +$5.13M +25.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $82.2M $23M +$3.83M +20% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $78.4M $20M +$596K +3.07% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $77.8M $18.8M +$1.81M +10.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $75.9M $20.4M +$2.88M +16.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $73.1M $19.1M -$346K -1.78% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $73.4M $19.4M +$2.15M +12.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $71.3M $17M +$2.46M +16.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $68.8M $17.5M +$1.09M +6.63% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 $67.7M $19.5M +$3.39M +21.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $64.3M $17.3M +$1.89M +12.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $62.4M $14.5M +$1.22M +9.14% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $61.2M $16.4M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $16.1M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 $15.4M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 $13.3M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.